PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAC8. A total of 17 filers reported holding PDL BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $3,118,000 | +3.8% | 2,371,000 | 0.0% | 0.01% | 0.0% |
Q3 2014 | $3,005,000 | -20.6% | 2,371,000 | 0.0% | 0.01% | -25.0% |
Q2 2014 | $3,785,000 | -40.4% | 2,371,000 | -49.0% | 0.01% | -42.9% |
Q1 2014 | $6,349,000 | +0.9% | 4,651,000 | 0.0% | 0.01% | -6.7% |
Q4 2013 | $6,293,000 | -12.9% | 4,651,000 | -17.1% | 0.02% | -21.1% |
Q3 2013 | $7,226,000 | +4.4% | 5,610,000 | +99900.0% | 0.02% | -5.0% |
Q2 2013 | $6,921,000 | – | 5,610 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LINDEN ADVISORS LP | 20,750,000 | $25,781,000 | 3.35% |
Sage Capital Management, LLC | 2,500,000 | $3,092,000 | 3.23% |
WHITEBOX ADVISORS LLC | 24,874,000 | $30,844,000 | 1.62% |
Castle Creek Arbitrage, LLC | 17,350,000 | $21,507,000 | 0.98% |
GUARDIAN LIFE INSURANCE CO OF AMERICA | 4,598,000 | $5,673,000 | 0.52% |
WOLVERINE ASSET MANAGEMENT LLC | 15,690,000 | $19,386,000 | 0.50% |
AMUNDI ASSET MANAGEMENT US, INC. | 25,195,000 | $31,084,000 | 0.13% |
Cutler Capital Management, LLC | 237,000 | $292,000 | 0.13% |
PALISADE CAPITAL MANAGEMENT, LP | 3,500,000 | $4,371,000 | 0.13% |
LAZARD ASSET MANAGEMENT LLC | 14,457,000 | $17,836,000 | 0.04% |